Insights

Biotechnology Expansion Oncimmune specializes in immuno diagnostics for cancer, autoimmune, and infectious diseases, presenting opportunities to collaborate with healthcare providers seeking innovative diagnostic solutions.

Global Presence With offices in the UK, Germany, and the USA, Oncimmune has a broad international reach, offering a foothold for expansion into new markets and partnerships with global pharmaceutical companies.

Cutting-Edge Tech Stack Utilizing a modern tech stack including LinkedIn Insight Tag and Salesforce Marketing Cloud Account Engagement, Oncimmune demonstrates a commitment to advanced digital solutions, appealing to tech-focused clients in the healthcare industry.

Strategic Funding Having secured significant funding and with reported revenue between $10M - $50M, Oncimmune displays financial stability and growth potential, making it an attractive opportunity for investment and service collaborations.

Competitive Landscape In comparison to similar companies like Genomic Health, Natera, and Guardant Health, Oncimmune's specialized focus on immuno diagnostics offers a competitive edge, positioning the company as a unique player in the market with distinct advantages.

Oncimmune Tech Stack

Oncimmune uses 8 technology products and services including Linkedin Insight Tag, WordPress, Modernizr, and more. Explore Oncimmune's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • WordPress
    Content Management System
  • Modernizr
    Javascript Libraries
  • Google Maps
    Maps
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • Open Graph
    Miscellaneous
  • Nginx
    Web Servers
  • Facebook
    Widgets

Media & News

Oncimmune's Email Address Formats

Oncimmune uses at least 1 format(s):
Oncimmune Email FormatsExamplePercentage
First.Last@oncimmune.comJohn.Doe@oncimmune.com
49%
FLast@oncimmune.comJDoe@oncimmune.com
1%
Last@oncimmune.comDoe@oncimmune.com
1%
First.Last@oncimmune.comJohn.Doe@oncimmune.com
49%

Frequently Asked Questions

Where is Oncimmune's headquarters located?

Minus sign iconPlus sign icon
Oncimmune's main headquarters is located at 1 Park Row Leeds, Yorkshire LS1 5AB GB. The company has employees across 5 continents, including EuropeNorth AmericaAfrica.

What is Oncimmune's phone number?

Minus sign iconPlus sign icon
You can contact Oncimmune's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Oncimmune's stock symbol?

Minus sign iconPlus sign icon
Oncimmune is a publicly traded company; the company's stock symbol is ONC.L.

What is Oncimmune's official website and social media links?

Minus sign iconPlus sign icon
Oncimmune's official website is oncimmune.com and has social profiles on LinkedIn.

How much revenue does Oncimmune generate?

Minus sign iconPlus sign icon
As of September 2024, Oncimmune's annual revenue reached $15M.

What is Oncimmune's SIC code NAICS code?

Minus sign iconPlus sign icon
Oncimmune's SIC code is 8071 - Medical Laboratories NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Oncimmune have currently?

Minus sign iconPlus sign icon
As of September 2024, Oncimmune has approximately 51 employees across 5 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Executive Officer: M. G.Chief Business Officer: C. B.Chief Technical Officer: H. Z.. Explore Oncimmune's employee directory with LeadIQ.

What industry does Oncimmune belong to?

Minus sign iconPlus sign icon
Oncimmune operates in the Biotechnology Research industry.

What technology does Oncimmune use?

Minus sign iconPlus sign icon
Oncimmune's tech stack includes Linkedin Insight TagWordPressModernizrGoogle MapsSalesforce Marketing Cloud Account EngagementOpen GraphNginxFacebook.

What is Oncimmune's email format?

Minus sign iconPlus sign icon
Oncimmune's email format typically follows the pattern of . Find more Oncimmune email formats with LeadIQ.

How much funding has Oncimmune raised to date?

Minus sign iconPlus sign icon
As of September 2024, Oncimmune has raised $6.7M in funding. The last funding round occurred on Sep 27, 2017 for $6.7M.

When was Oncimmune founded?

Minus sign iconPlus sign icon
Oncimmune was founded in 2006.
Oncimmune

Oncimmune

Biotechnology ResearchYorkshire, United Kingdom51-200 Employees

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners. 

Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients.

Oncimmune is headquartered in the UK, with a discovery research centre in Dortmund, Germany and an office in Cambridge MA, USA.

Section iconCompany Overview

Headquarters
1 Park Row Leeds, Yorkshire LS1 5AB GB
Phone number
SIC Code
8071 - Medical Laboratories
Stock Symbol
ONC.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $6.7M

    Oncimmune has raised a total of $6.7M of funding over 5 rounds. Their latest funding round was raised on Sep 27, 2017 in the amount of $6.7M.

  • $10M$50M

    Oncimmune's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $6.7M

    Oncimmune has raised a total of $6.7M of funding over 5 rounds. Their latest funding round was raised on Sep 27, 2017 in the amount of $6.7M.

  • $10M$50M

    Oncimmune's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.